Patent Assignment
Reel/Frame 030091/0737
Change of Name
Recorded: 2013-03-26
Pages: 28
Assignor
NYCOMED GMBH
Executed: 2012-11-14
Assignee
TAKEDA GMBH
BYK-GULDEN-STRASSE 2, KONSTANZ, 78467, GERMANY
Covered Properties
(30)
Process for the rehydration of magaldrate powder
Application:
10/399,713 →
Publication:
US US20040018249A1
Process for the Production of 16,17-[{Cyclohexylmethylen)Bis(Oxy)]-11,21-Dihydroxy-Pregna-1,4-Dien-3,20-Dion or Its 21-Isobutyrat by Transketalisation
Medicinal Product Package for Eradication Therapy
A Suppository Composition Which Is a Spray-Dried Suspension of an Acid-Labile Proton Pump Inhibitor in a Solvent Solution of a Sterol and Polymer
Novel Suppository Form Comprising an Acid-Labile Active Compound
Patent:
6,383,510 →
Application:
09/554,079 →
Freeze-Dried Pantoprazole Preparation and Pantoprazole Injection
Freeze-Dried Pantoprazole Preparation and Pantoprazole Injection
Freeze-dried pantoprazole preparation and pantoprazole injection
Rapidly Disintegrating Tablet Comprising an Acid-Labile Active Ingredient
Pharmaceutical Preparation in the Form of a Paste Comprising an Acid-Labile Active Ingredient
Pharmaceutical Preparation in the Form of a Supension Comprising an Acid-Labile Active Ingredient
6-Phenylbenzonaphthyridines
Pharmaceutical Preparation Comprising an Active Dispersed on a Matrix
Pharmaceutical Preparation Comprising an Active Dispersed on a Matrix
Phthalazinone-Piperidino-Derivatives as PDE4 Inhibitors
Phthalazinone-Piperidino-Derivatives as PDE4 Inhibitors
Phthalazinone-Piperidino-Derivatives as PDE4 Inhibitors
Combination of a Nsaid and a Pde-4 Inhibitor
Ciclesonide Contained Pharmaceutical Composition for Application to Mucosa
Patent:
6,767,901 →
Application:
10/110,629 →
Ciclesonide Containing Aqueous Pharmaceutical Composition
Patent:
8,383,611 →
Application:
10/110,632 →
Novel Benzonaphthyridines
Novel Benzonaphthyridines
Novel Use of Pulmonary Surfactant
Topically Applicable Pharmaceutical Preparation
Application:
13/219,056 →
Publication:
US US20110313005A1
Topically applicable pharmaceutical preparation
Application:
12/149,250 →
Publication:
US US20080280958A1
Process for preparing crystalline ciclesonide with defined particle size
Use of PDE4 Inhibitors for the Treatment of Diabetes Mellitus
2-Hydroxy-6-Phenylphenanthridines as Pde-4 Inhibitors
2-Hydroxy-6-Phenylphenanthridines as Pde-4 Inhibitors
Ciclesonide Containing Aqueous Pharmaceutical Composition
Application:
13/688,659 →
Publication:
US US20130095146A1
Related Assignments
(22)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Oct 25, 2002
From: LINDER, RUDOLF; DIETRICH, RANGO
To: ALTANA PHARMA AG
Reel/Frame 013425/0992 →
Change of Name
Sep 4, 2007
From: ALTANA PHARMA AG
To: NYCOMED GMBH
Reel/Frame 019781/0225 →
Change of Name
Sep 4, 2007
From: ALTANA PHARMA AG
To: NYCOMED GMBH
Reel/Frame 019783/0625 →
Merger
Jul 28, 2015
From: TAKEDA GMBH
To: NYCOMED ASSET MANAGEMENT GMBH
Reel/Frame 036193/0178 →
Merger
Jul 28, 2015
From: NYCOMED ASSET MANAGEMENT GMBH
To: NYCOMED GERMANY HOLDING GMBH
Reel/Frame 036201/0261 →
Merger
Jul 28, 2015
From: TAKEDA GMBH
To: NYCOMED ASSET MANAGEMENT GMBH
Reel/Frame 036193/0224 →
Merger
Jul 28, 2015
From: NYCOMED ASSET MANAGEMENT GMBH
To: NYCOMED GERMANY HOLDING GMBH
Reel/Frame 036201/0478 →
Change of Name
Jul 29, 2015
From: NYCOMED GERMANY HOLDING GMBH
To: TAKEDA GMBH
Reel/Frame 036205/0192 →
Change of Name
Jul 29, 2015
From: NYCOMED GERMANY HOLDING GMBH
To: TAKEDA GMBH
Reel/Frame 036205/0179 →
Assignment of Assignor's Interest
Jan 11, 2017
From: TAKEDA GMBH
To: ASTRAZENECA AB
Reel/Frame 041328/0362 →
Assignment of Assignor's Interest
Dec 10, 2018
From: ASTRAZENECA AB
To: COVIS PHARMA B.V.
Reel/Frame 047761/0435 →
Security Interest
Dec 20, 2018
From: COVIS PHARMA B.V.
To: CAPITAL ONE, NATIONAL ASSOCIATION, AS COLLATERAL AGENT
Reel/Frame 047834/0926 →
Security Interest
Mar 12, 2020
From: COVIS PHARMA B.V.
To: CAPITAL ONE, NATIONAL ASSOCIATION, AS COLLATERAL AGENT
Reel/Frame 052095/0262 →
Release of Security Interest
Mar 17, 2020
From: CAPITAL ONE, NATIONAL ASSOCIATION, AS COLLATERAL AGENT
To: COVIS PHARMA B.V.
Reel/Frame 052142/0961 →
Business Transfer and Contribution Agreement
Dec 16, 2020
From: COVIS PHARMA B.V.
To: COVIS PHARMA GMBH
Reel/Frame 054793/0416 →
Security Interest
Feb 22, 2021
From: COVIS PHARMA GMBH
To: CAPITAL ONE, NATIONAL ASSOCIATION, AS COLLATERAL AGENT
Reel/Frame 055354/0063 →
Notice of Grant of Security Interest in Intellectual Property (First Lien)
Jan 4, 2022
From: COVIS PHARMA GMBH
To: WILMINGTON TRUST, NATIONAL ASSOCIATION, AS COLLATERAL AGENT
Reel/Frame 058640/0787 →
Release of Security Interest
Feb 18, 2022
From: CAPITAL ONE, NATIONAL ASSOCIATION
To: COVIS PHARMA GMBH
Reel/Frame 059043/0226 →
Release of Security Interest
Feb 18, 2022
From: CAPITAL ONE, NATIONAL ASSOCIATION
To: COVIS PHARMA B.V.
Reel/Frame 059043/0239 →
Notice of Grant of Security Interest in Intellectual Property (Second Lien)
Feb 18, 2022
From: COVIS PHARMA GMBH
To: BARCLAYS BANK PLC, AS COLLATERAL AGENT
Reel/Frame 059232/0514 →
Release of Security Interest
Jun 2, 2023
From: BARCLAYS BANK PLC
To: COVIS PHARMA GMBH
Reel/Frame 063841/0208 →
Release of Security Interest in Patents
Mar 17, 2025
From: WILMINGTON TRUST, NATIONAL ASSOCIATION, AS COLLATERAL AGENT
To: COVIS PHARMA GMBH
Reel/Frame 070537/0122 →